To more definitively demonstrate the relevance of 2P‐Im activation of the UPR in the induction of MM apoptosis, we generated variants of the RPMI‐8226 cell line using CRISPR‐Cas9 to disrupt either PERK or DDIT3 (CHOP) expression. This evidence concerns the gene DDIT3 and Miyoshi myopathy.